New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
07:04 EDTACST, NEPTAcasti Pharma announces resignation of CFO
Acasti Pharma (ACST) announces the resignation of Xavier Harland as CFO of Acasti with immediate effect. Effective immediately, the functions of CFO for Acasti will be assumed by André Godin, Interim president and CEO of Acasti, who is currently also CFO of Neptune Technologies and Bioressources (NEPT).
News For ACST;NEPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
08:08 EDTACSTAcasti Pharma announces positive top-line pharmacokinetic results
Subscribe for More Information
September 29, 2014
08:10 EDTACSTAcasti Pharma reports CaPre Phase II trial met primary endpoint
Acasti Pharma announces successful top-line results for its Phase II double blind, placebo controlled trial, or TRIFECTA, assessing the safety and efficacy of CaPre for the treatment of patients with hypertriglyceridemia. CaPre, Acasti's investigational new drug candidate, is composed of a patent-protected highly concentrated novel omega-3 phospholipid for the prevention and treatment of certain cardiometabolic disorders. CaPre successfully met the trial's primary endpoint achieving a statistically significant mean placebo-adjusted decrease in triglycerides from baseline to week-12, with reductions of 36.4% for 1 gram and 38.6% for 2 grams.
September 23, 2014
08:22 EDTNEPTNeptune reaches annualized production capacity of 100 metric tons at Sherbrooke
Neptune Technologies announces that its Sherbrooke plant is now operating at an annualized production capacity of 100 metric tons and customer shipments of Neptune manufactured krill oil products have commenced.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use